Anti-DLL3重组抗体|科研级 Rovalpituzumab ( 洛伐妥珠单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-DLL3重组抗体|科研级 Rovalpituzumab ( 洛伐妥珠单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-DLL3重组抗体|科研级 Rovalpituzumab ( 洛伐妥珠单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1386

Alias

科研级 Rovalpituzumab ( 洛伐妥珠单抗 ), Anti-DLL3 Recombinant Antibody, Research Grade Rovalpituzumab

Molecular Name

Rovalpituzumab

Size

1mg, 5mg

CAS Number

1613313-01-1

Isotype

IgG1 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

DLL3[Homo sapiens]

Background

Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by Stemcentrx and was purchased by AbbVie. It was tested for use in small-cell lung cancer, but development was terminated after unsuccessful phase III trial.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ